CureVac Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technology
CureVac has filed a patent infringement lawsuit against Moderna, alleging that Moderna's Spikevax vaccine infringes on CureVac's mRNA stabilization technology. The lawsuit seeks royalties from Spikevax sales, and CureVac was recently acquired by BioNTech, which has also filed a separate lawsuit against Moderna. The case is part of a broader trend of patent disputes in the biotech industry over COVID-19 vaccine revenue.
Tickers: $BNTX $CVAC $MRNA $PFE
Topics: BioNTech CureVac legal dispute Moderna mRNA technology patent infringement Pfizer